Endothelial Cell–Derived Microparticles in Allogeneic Hematopoietic Stem Cell Recipients
- 27 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 81 (10) , 1405-1409
Abstract
Background. Alterations of microparticles derived from different cell types are described in a number of diseases associated with inflammation and hemostatic disorders. Methods. In this prospective study, we firstly analyzed endothelial cell derived microparticles (EMP) in 19 hematopoietic stem cell recipients. Cultured human umbilical vein endothelial cells (HUVEC) stimulated with tumor necrosis factor-alpha (TNF-alpha) served as positive controls. EMP were analyzed by fluorescent activated cell sorting (FACS), detecting the particels via expression of CD62 (E-selectin) and anionic phospholipids binding to annexin V. Results. EMP were not significantly influenced by conditioning regimens with non-myeloablative chemotherapy and 4 Gy total body irradiation (TBI) or by myeloablative regimens containing 12 Gy TBI. During acute graft versus host disease (aGVHD), significantly higher levels of EMP were detected than in patients without aGVHD (18.5/μl s=10.1 vs. 14.6/μl SD=11.5; P=0.004) while infectious complications did not alter EMP levels significantly. Immunosuppressive therapy with corticosteroids tendentially elevated EMP levels. HUVEC treated with TNF-alpha 1 ng/ml, 10 ng/ml and 100 ng/ml released significantly more EMP than unstimulated cultures (30.0/μl ss=13.6 vs. 126.8/μl SD=66.9, P=0.032 / vs. 683.3/μl SD=349.9; P=0.03 / vs. 489.3 s=184.4; P=0.013). Conclusions. Elevation of EMP during aGVHD might express severe endothelial cell injury within this complication after hematopoietic stem cell transplantation and might serve as a diagnostic test for early differentiation of aGVHD from other transplanted related complications.Keywords
This publication has 24 references indexed in Scilit:
- Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndromeThrombosis and Haemostasis, 2004
- Microparticles in cardiovascular diseasesCardiovascular Research, 2003
- Elevated plasma endothelial microparticles in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2003
- High levels of circulating endothelial microparticles in patients with acute coronary syndromesAmerican Heart Journal, 2003
- Effects of Severe Hypertension on Endothelial and Platelet MicroparticlesHypertension, 2003
- Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosisThrombosis Research, 2003
- Microparticle subpopulations are increased in preeclampsia: Possible involvement in vascular dysfunction?American Journal of Obstetrics and Gynecology, 2002
- Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor–dependent procoagulant activityBlood, 2002
- Elevated plasma endothelial microparticles in multiple sclerosisNeurology, 2001
- Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active diseaseBritish Journal of Haematology, 2001